Derivative Liabilities - Fair Value
AbbVie Derivative Liabilities - Fair Value decreased by 37.4% to $338.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 34.1%, from $252.00M to $338.00M. Over 5 years (FY 2020 to FY 2025), Derivative Liabilities - Fair Value shows an upward trend with a 26.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in liabilities suggests unfavorable market movements for the company's hedges, while a decrease indicates a reduction in potential settlement obligations.
Detailed definition
This represents the fair value of derivative financial instruments that are currently in a liability position. These lia...
Peer comparison
Standard for energy companies; peers with similar hedging profiles will show comparable volatility in this line item.
derivative_liabilities_fair_valueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.00M | $49.00M | $37.00M | $213.00M | $318.00M | $509.00M | $524.00M | $544.00M | $542.00M | $531.00M | $496.00M | $428.00M | $341.00M | $446.00M | $266.00M | $252.00M | $880.00M | $690.00M | $540.00M | $338.00M |
| QoQ Change | — | -51.0% | -24.5% | +475.7% | +49.3% | +60.1% | +2.9% | +3.8% | -0.4% | -2.0% | -6.6% | -13.7% | -20.3% | +30.8% | -40.4% | -5.3% | +249.2% | -21.6% | -21.7% | -37.4% |
| YoY Change | — | — | — | — | +218.0% | +938.8% | >999% | +155.4% | +70.4% | +4.3% | -5.3% | -21.3% | -37.1% | -16.0% | -46.4% | -41.1% | +158.1% | +54.7% | +103.0% | +34.1% |
Derivative Liabilities - Fair Value at Other Companies
Frequently Asked Questions
- What is AbbVie's derivative liabilities - fair value?
- AbbVie (ABBV) reported derivative liabilities - fair value of $338.00M in Q1 2026.
- How has AbbVie's derivative liabilities - fair value changed year-over-year?
- AbbVie's derivative liabilities - fair value increased by 34.1% year-over-year, from $252.00M to $338.00M.
- What is the long-term trend for AbbVie's derivative liabilities - fair value?
- Over 5 years (2020 to 2025), AbbVie's derivative liabilities - fair value has grown at a 26.6% compound annual growth rate (CAGR), from $166.00M to $540.00M.
- What does derivative liabilities - fair value mean?
- The total market value of all derivative contracts that are currently resulting in a loss.